Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, L ., AntimiRNA-based therapy for glucose intolerance and insulin resistance (DM): Tumor suppresor ING1b inhibits ß-cell mass and function via up regulation of its target gene, 29/August/2014, 08.31 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Web: http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
* Research cooperation
Significance: ING1b, by increasing the expression of its target gene, it may decrease ß-cell mass (insulin secreting cells). Thus, pharmacological formulations encompassing “ING1b inhibitors” may be used to treat DM.
